Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma
Clinical trial NCT04730219 · UNKNOWN
Trial details
- NCT number
- NCT04730219
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-11
- Primary completion
- 2024-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.